Trevi Therapeutics, Inc.TRVINASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-36.46
↓ 362% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
-7.89
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -36.46 | -354.7% |
| 2024 | -8.02 | -125.5% |
| 2023 | -3.56 | +17.9% |
| 2022 | -4.33 | -3367.4% |
| 2021 | 0.13 | +133.1% |
| 2020 | -0.40 | -7.3% |
| 2019 | -0.37 | +87.5% |
| 2018 | -2.97 | +54.9% |
| 2017 | -6.60 | +59.7% |
| 2016 | -16.37 | - |